American Century Companies
GNMK

American Century Companies’s GenMark Diagnostics, Inc GNMK Stock Holding History

American Century Companies’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,087
Closed -$220K – 2270
2020
Q4 		$220K Buy
+15,087
New +$200K ﹤0.01% 1845

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies's GNMK Position: Q1 2021 in Review

American Century Companies sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 15,087 shares — an estimated $220K sold.

American Century Companies first reported a position in GNMK in Q4 2020 and held it in 1 quarter. The position peaked at $220K in Q4 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • American Century Companies reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • American Century Companies sold 15,087 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $220K.
  • American Century Companies first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 1 quarter.
  • American Century Companies's GenMark Diagnostics, Inc position peaked at $220K in Q4 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on American Century Companies's 13F filing for Q1 2021, filed 14 May 2021.